BioNTech Investor News Health Press Releases — RSS Feed & Live Monitoring
PPN World tracks the BioNTech Investor News RSS feed in real time — 4 releases indexed over the last 30 days, the newest arrived 6 d ago. Follow it with saved-search alerts, AI summaries, and full-text search, or plug the RSS URL below into your own reader.
About this feed
BioNTech Investor News is one of the 1,400+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Health, filed under Germany in our country index. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. BioNTech Investor News is a low-volume specialist wire — 4 releases over the last 30 days: the kind of source worth an alert rather than a scroll.
Track BioNTech Investor News in real time in PPN World
Every BioNTech Investor News release lands in the cockpit seconds after it publishes — deduplicated, classified, with saved-search alerts and AI summaries, alongside 1,400+ other wires. 72-hour free trial, no card required.
Start the free trial →Latest BioNTech Investor News press releases
- BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 20266 d ago
Pumitamig plus B7H3-targeting elfetabart drozuntecan delivers the first data in lung cancer for any PD-(L)1xVEGF bispecific immunomodulator combined with an antibody-drug conjugate, underscoring BioNT…
- BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update22 d ago
Guido Oelkers, Ph.D., appointed to BioNTech Management Board as Chief Executive Officer, taking office by February 1, 2027, at the latest Advanced diversified pipeline now with 14 ongoing pivotal clin…
- BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update22 d ago
Conference call and webcast scheduled for August 4, 2026, at 8:00 a.m. EDT (2:00 p.m. CEST)
- BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer23 d ago
Mainz, Germany, August 3, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that its Supervisory Board has appointed Guido Oelkers, Ph.D., to the Manageme…
- BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer23 d ago
Mainz, Germany, August 3, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that its Supervisory Board has appointed Guido Oelkers, Ph.D., to the Manageme…
- European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union28 d ago
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion dos…
- BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 202636 d ago
MAINZ, Germany, July 21, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August 4, 2026. Add…
- BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 202636 d ago
MAINZ, Germany, July 21 , 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2026 on Tuesday, August 4, 2026. Ad…
- Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial88 d ago
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung cancer across PD-L1…
- BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting96 d ago
Pumitamig data from the ongoing Phase 2/3 ROSETTA Lung-02 trial in first-line non-small cell lung cancer mark the third global data set to consistently show encouraging anti-tumor activity for pumitam…
- BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting96 d ago
Pumitamig data from the ongoing Phase 2/3 ROSETTA Lung-02 trial in first-line non-small cell lung cancer mark the third global data set to consistently show encouraging anti-tumor activity for pumitam…
- BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026103 d ago
MAINZ, Germany, May 15, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) held its Annual General Meeting (“AGM”) today. A total of 92 per cent of the share capital was…
The newest releases on this wire stream live for PPN World members.
Frequently asked questions
How do I follow BioNTech Investor News press releases in real time?+
How often are BioNTech Investor News press releases picked up?+
What kind of press releases does BioNTech Investor News publish?+
Related feeds
- Presseportal
- PR-Inside
- lifePR (DE)
- PresseBox (DE)
- German Federal Government (Bundesregierung)
- Bayerische Staatsregierung (Bayerisches Landesportal)
- Medienservice Sachsen
- Baden-Württemberg Landesregierung (Alle Meldungen)
- Sachsen-Anhalt Landesportal (Pressemitteilungen der Ministerien)
- Schleswig-Holstein Landesregierung (Alle Medieninformationen)